The USFDA has recently approved 10 mg ARICEPT® (donepezil HCl tablets) for the treatment of severe Alzheimer's disease – making ARICEPT® the first and only treatment approved for the full spectrum of Alzheimer’s disease: mild, moderate, severe.
According to Sharon Richardson, Ph.D., senior director, Medical Affairs, Eisai Inc.:
"For the first time ever, the millions of people affected by Alzheimer's disease and the families, caregivers and healthcare professionals who care for them now have a once-daily therapy, Aricept, to treat the symptoms of every stage of this disease.
This milestone exemplifies Eisai's and Pfizer's commitment to improving the lives of families living with Alzheimer's disease and advancing the scientific understanding of this devastating form of dementia.”
It should be noted the ARICEPT® was co-developed by Eisai, Inc.(15723356) and Pfizer (NYSE: PFE)
The said approval was based on results of a pivotal six-month, multi-center, randomized, double-blind, placebo-controlled clinical trial involving 248 Swedish nursing home patients with severe AD (Mini Mental State Exam scores 1-10).
Find more details from Eisai’s press release.
.jpg)
Its great that there is such a high improvement rate among the patients. Here is an video for Alzheimer Treatment. Watch this: http://www.youtube.com/watch?v=wq7INUBbWdU
Posted by: california drug northern rehab | November 5, 2007 7:29 AM | Permalink to Comment